Bank Julius Baer & Co’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,503
Closed -$170K 566
2023
Q2
$170K Sell
8,503
-543
-6% -$10.5K ﹤0.01% 422
2023
Q1
$171K Sell
9,046
-1,478
-14% -$32.7K ﹤0.01% 447
2022
Q4
$239K Sell
10,524
-2,633
-20% -$59.5K ﹤0.01% 405
2022
Q3
$348K Buy
13,157
+1,789
+16% +$53.1K ﹤0.01% 360
2022
Q2
$281K Sell
11,368
-4,418
-28% -$110K ﹤0.01% 386
2022
Q1
$524K Sell
15,786
-602
-4% -$16.7K ﹤0.01% 344
2021
Q4
$536K Buy
16,388
+9,766
+147% +$333K ﹤0.01% 418
2021
Q3
$278K Sell
6,622
-765
-10% -$27.5K ﹤0.01% 512
2021
Q2
$287K Sell
7,387
-1,879
-20% -$67.2K ﹤0.01% 525
2021
Q1
$316K Sell
9,266
-9,914
-52% -$423K ﹤0.01% 507
2020
Q4
$870K Buy
19,180
+7,370
+62% +$258K 0.01% 375
2020
Q3
$278K Buy
11,810
+10,474
+784% +$341K ﹤0.01% 463
2020
Q2
$287K Sell
1,336
-8,446
-86% -$315K ﹤0.01% 421
2020
Q1
$316K Buy
+9,782
New +$408K 0.01% 363

Other funds holding RGNX